Answers are grounded in this paper and cite their sources.
Zaleplon is licensed for the short‐term treatment of insomnia. Excessive usage causes side effects; hence, the drug is controlled. Identifying zaleplon in a drug abuser requires an isotope‐labeled internal standard. This work presents a synthesis of stable isotope‐labeled internal standard for zaleplon, zaleplon‐d5, by a five‐step synthetic sequence.
No takes yet. Share an insight, caveat, or question.
Shaikh et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: